Informes de posicionamiento terapéutico: utilidad y transparencia

Katharina Elisabeth Fischer, Thomas Heisser, Tom Stargardt, Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia Health Policy. ,vol. 120, pp. 1115- 1122 ,(2016) , 10.1016/J.HEALTHPOL.2016.08.001

Kristian Reich, April W. Armstrong, Peter Foley, Michael Song, Yasmine Wasfi, Bruce Randazzo, Shu Li, Y.-K. Shen, Kenneth B. Gordon, Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator–controlled VOYAGE 2 trial Journal of the American Academy of Dermatology. ,vol. 76, pp. 418- 431 ,(2017) , 10.1016/J.JAAD.2016.11.042

Andrew Blauvelt, Kim A. Papp, Christopher E.M. Griffiths, Bruce Randazzo, Yasmine Wasfi, Yaung-Kaung Shen, Shu Li, Alexa B. Kimball, Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial Journal of the American Academy of Dermatology. ,vol. 76, pp. 405- 417 ,(2017) , 10.1016/J.JAAD.2016.11.041

Zarif K Jabbar-Lopez, Zenas ZN Yiu, Victoria Ward, Lesley S Exton, M Firouz Mohd Mustapa, Eleanor Samarasekera, A David Burden, Ruth Murphy, Caroline M Owen, Richard Parslew, Vanessa Venning, Richard B Warren, Catherine H Smith, None, Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis Journal of Investigative Dermatology. ,vol. 137, pp. 1646- 1654 ,(2017) , 10.1016/J.JID.2017.04.009

R.G. Langley, T.‐F. Tsai, S. Flavin, M. Song, B. Randazzo, Y. Wasfi, J. Jiang, S. Li, L. Puig, Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial. British Journal of Dermatology. ,vol. 178, pp. 114- 123 ,(2018) , 10.1111/BJD.15750

Zarif K. Jabbar-Lopez, Zenas Z.N. Yiu, Victoria Ward, Lesley S. Exton, M. Firouz Mohd Mustapa, Eleanor Samarasekera, A. David Burden, Ruth Murphy, Caroline M. Owen, Richard Parslew, Vanessa Venning, Richard B. Warren, Catherine H. Smith, Author Reply to: Letter to the Editor in Response to recently published article, 'Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis' Journal of Investigative Dermatology. ,vol. 137, pp. 2644- 2646 ,(2017) , 10.1016/J.JID.2017.07.848

Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Giao Do, Camille Hua, Canelle Mazaud, Catherine Droitcourt, Carolyn Hughes, John R Ingram, Luigi Naldi, Olivier Chosidow, Laurence Le Cleach, Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews. ,vol. 12, pp. 0- 0 ,(2017) , 10.1002/14651858.CD011535.PUB2

Chris Cameron, Brian Hutton, Cheryl Druchok, Sean McElligott, Sandhya Nair, Agata Schubert, Aaron Situ, Abhishek Varu, Reggie Villacorta, Importance of assessing and adjusting for cross-study heterogeneity in network meta-analysis: a case study of psoriasis. Journal of Comparative Effectiveness Research. ,vol. 7, pp. 1037- 1051 ,(2018) , 10.2217/CER-2018-0065

M. Núñez, T. Huete, P. de la Cueva, J.A. Sacristán, S. Hartz, T. Dilla, Evaluación de la eficiencia de los tratamientos biológicos en la psoriasis moderada a grave en España: análisis de coste por número necesario a tratar (NNT) Actas Dermo-Sifiliográficas. ,vol. 110, pp. 546- 553 ,(2019) , 10.1016/J.AD.2018.10.017